Robust glucose control and weight loss after 6 weeks of treatment with MEDI0382, a balanced GLP-1/Glucagon receptor dual agonist, in patients with type 2 diabetes

Authors
Category Primary study
ConferenceDiabetologia
Year 2018
This article has no abstract
Epistemonikos ID: 124ba043a07bd38d628bc49296c855b1b7023c6d
First added on: Apr 30, 2026